Joan Walker to Oncolytic Virotherapy
This is a "connection" page, showing publications Joan Walker has written about Oncolytic Virotherapy.
Connection Strength
0.146
-
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 09; 146(3):477-483.
Score: 0.146